News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Syrrx, Inc. Researchers Report Atomic Structure Of Human HSD-1, An Important Target For The Potential Treatment Of Diabetes


10/19/2005 5:12:05 PM

Syrrx Inc., a next generation structure-based drug discovery company, today reported the publication of the atomic structure of human 11(beta)-hydroxysteroid dehydrogenase type-1 (HSD-1). HSD-1 inhibitors are being investigated in clinical trials for the potential treatment of type II diabetes.

Read at BioSpace.com


comments powered by Disqus
Syrrx, Inc.
Roche
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES